Skip To Content

Michel Lussier, General Manager

Michel Lussier serves as Chief Executive Officer of Metronom Health, Inc. and is an advisor to other Fjord Ventures portfolio companies. Michel is also the co-founder of Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell therapies, as well as the co-founder of Cardio3 BioSciences and has served as Chairman of the Board of Directors since Cardio3 BioSciences’ inception in July 2007. He has been the Managing Director of Volcano Europe since March 2006. From July 2002, Michel has also served as Volcano President, General Manager of Europe, Africa and Middle East and Global Clinical and Scientific Affairs. In February 2002, he founded Medpole S.A./N.V., a European distribution incubator for medical device start-up companies located in Belgium. From October 1998 to January 2002, he served as the Vice President and General Manager, Europe, of Novoste Corp., a medical technology company.

Prior to Novoste, Michel founded and led the European subsidiary of InControl Corp., until its acquisition by Guidant Corporation. He brings 15 years of operational experience with Medtronic, Inc., where he drove the company's core business in Europe as Business Director, Cardiac Pacing. Additionally, Michel holds a director mandate in Medpole S.A. and has chaired a number of committees within Eucomed, as well as serving on several start-up boards for medical devices. Michel received a B.S. in Electrical Engineering and an M.S. in Biomedical Engineering from the University of Montreal, Canada, and an M.B.A. from INSEAD, France.



You are now leaving the website of Metronom Health, Inc. and entering a third-party website over which Metronom Health, Inc. has no control. Neither Metronom Health, Inc. nor its subsidiaries or affiliates, are responsible for the content of third-party websites hyperlinked from this page or any hyperlink contained in a hyperlinked website, nor do they guarantee or endorse the information, recommendations, products or services offered on third-party websites.

Continue Cancel